Carbapenemases are enzymes produced by certain bacteria that Hydrolyze carbapenem antibiotics, rendering them ineffective and leading to Multidrug-resistant infections. These enzymes pose a significant Challenge to healthcare due to their ability to Spread rapidly among bacterial populations, necessitating the Development of new treatment strategies and Infection Control Measures.